T1	Participants 941 1002	9541 patients, 174 centers participated in the HOPE-TOO trial
T2	Participants 723 889	patients at least 55 years old with vascular disease or diabetes mellitus was extended (HOPE-The Ongoing Outcomes [HOPE-TOO]) between April 16, 1999, and May 26, 2003
T3	Participants 1007 1211	7030 patients enrolled at these centers, 916 were deceased at the beginning of the extension, 1382 refused participation, 3994 continued to take the study intervention, and 738 agreed to passive follow-up
